Columbia's T32 program offers doctoral students multidisciplinary training and mentorship in clinical and translational research to prepare them for careers as translational scientists.
Funder: Columbia University Irving Medical Center
Due Dates: August 10, 2026 (full application deadline)
Funding Amounts: NIH NRSA predoctoral stipend, tuition/fees, health insurance, and childcare allowance for up to 2 years (renewable annually, NIH-set amounts)
Summary: Provides Columbia doctoral students with structured, multidisciplinary training and mentorship in clinical and translational research.
The Predoctoral T32 Training Program at Columbia University Irving Medical Center offers advanced predoctoral trainees comprehensive, multidisciplinary training in clinical and translational research. Supported by the NIH NRSA T32 mechanism and embedded within Columbia’s Clinical and Translational Science Award (CTSA) hub, the program is disease-agnostic and supports research across the clinical and translational spectrum. Trainees receive mentored research experience, structured coursework, and career development programming designed to complement their doctoral studies, with a strong emphasis on multidisciplinary mentorship, team science, and the translation of research findings into meaningful health impact. The program is designed to prepare participants for successful careers as translational scientists.